Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

被引：49
|
作者：
Rolston, Kenneth V. I. [1 ]
Gerges, Baghat [1 ]
Shelburne, Samuel [1 ]
Aitken, Samuel L. [2 ]
Raad, Issam [1 ]
Prince, Randall A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2020年 / 64卷 / 05期
关键词：
Gram-negative isolates; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; cefiderocol; VITRO ANTIMICROBIAL ACTIVITY; SIDEROPHORE CEPHALOSPORIN; S-649266;
D O I：
10.1128/AAC.01955-19
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at <= 4 mg/liter. It had potent activity against extended-spectrum beta-lactamase-positive Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE), and nonfermenting Gram-negative bacilli, including Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Acinetobacter species isolates. Amikacin, ceftazidime-avibactam, and meropenem had appreciable activity against non-CRE Enterobacteriaceae. No comparators were active against multidrug-resistant P. aeruginosa isolates. Only trimethoprim-sulfamethoxazole had appreciable activity against S. maltophilia isolates. Overall, cefiderocol was associated with the lowest level of resistance.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014-2018 studies in Italy x2729;
    Stracquadanio, Stefano
    Torti, Eleonora
    Longshaw, Christopher
    Henriksen, Anne Santerre
    Stefani, Stefania
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 390 - 398
  • [22] In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17
    Wohlfarth, Esther
    Kresken, Michael
    Deuchert, Fabian
    Gatermann, Soeren G.
    Pfeifer, Yvonne
    Pfennigwerth, Niels
    Seifert, Harald G.
    Higgins, Paul
    Werner, Guido
    ANTIBIOTICS-BASEL, 2023, 12 (05):
  • [23] In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer
    Rolston, KVI
    Ho, DH
    LeBlanc, B
    Streeter, H
    Dvorak, T
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 15 - 22
  • [24] In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
    Monogue, Marguerite L.
    Desai, Dhara
    Pybus, Christine A.
    Sanders, James M.
    Clark, Andrew E.
    Greenberg, David E.
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [25] Antifungal activity of a novel triazole and comparators against a large collection of identified Aspergillus isolates
    Abbasi, Kiana
    Ahangarkani, Fatemeh
    Badali, Hamid
    MEDICAL MYCOLOGY, 2022, 60 (SUPP 1) : 48 - 48
  • [26] In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates
    Rezaei-Matehkolaei, Ali
    Khodavaisy, Sadegh
    Alshahni, Mohamad Mahdi
    Tamura, Takashi
    Satoh, Kazuo
    Abastabar, Mahdi
    Shokoohi, Gholam Reza
    Ahmadi, Bahram
    Kord, Mohammad
    Taghipour, Simin
    Makimura, Koichi
    Badali, Hamid
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (05)
  • [27] Activity of ertapenem and comparators against recent clinical isolates from intra-abdominal abscesses (SMART 2009)
    Hawser, Stephen P.
    JOURNAL OF INFECTION, 2011, 62 (06) : 496 - 497
  • [28] In Vitro Activity of Cefiderocol Against Multidrug-Resistant Gram-Negative Clinical Isolates
    Boyd, Sandra
    Anderson, Karen
    Karlsson, J. Kamile Rasheed Maria
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S291 - S292
  • [29] Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance
    Simner, Patricia J.
    Beisken, Stephan
    Bergman, Yehudit
    Posch, Andreas E.
    Cosgrove, Sara E.
    Tamma, Pranita D.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (07):
  • [30] In Vitro Activity of Cefiderocol against a Global Collection of Carbapenem-Resistant Acinetobacter baumannii Isolates
    Seifert, Harald
    Mueller, Carina
    Stefanik, Danuta
    Higgins, Paul G. G.
    Wohlfarth, Esther
    Kresken, Michael
    ANTIBIOTICS-BASEL, 2023, 12 (07):
12345